 |
|
 |
Medical Supplies |
|
|
U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics, and Surgical Equipment, The
Publication Date September 2006
Publisher Business Communications Company
Product Type Report
Pages 144
ISBN Number not applicable
Product Code BCC045
|
|
|
Summary
The aging of the population in the United States will result in a two-fold increase in the 65 and over population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. Additionally, current market competitors will endure pressure from the industry to continually provide advances in therapies and equipment and to compete with emerging competitors, who focus significantly on unmet needs of the ophthalmic consumer, including treatments for back of the eye conditions. The industry is likely to experience a burst of new products and heavy competition as the U.S. ophthalmic market advances.
This BCC Research report, U.S. Market for Prescription Ophthalmic Pharmaceuticals, Devices, Diagnostics and Surgical Equipment, provides a comprehensive description of conditions and diseases affecting the eye and products used for treatment. The study includes information regarding the incidence and prevalence of eye conditions and risk factors associated with those conditions. The major product segments presented with in-depth market and competitive analyses are ophthalmic prescription drugs, devices, diagnostics and surgical procedures. Research and development activities are included with an emphasis on segments offering benefits to aging populations.
Scope Of Study
This report contains:
- A thorough evaluation of the U.S. prescription ophthalmic pharmaceutical, device, diagnostic, and surgical market, with forecasts to 2011
- Market analysis focused on specific diseases and conditions such as cataract, glaucoma and refractive treatments
- Information regarding incidence and prevalence of eye conditions and risk factors associated with those conditions
- Examination of research and development activities with an emphasis on segments offering benefits to aging populations
- Profiles of the major companies in the industry as well as a detailed patent analysis.
Report Highlights
- The U.S. ophthalmic market is worth $9.6 billion in 2006, up from $8.8 billion in 2005. At an average annual growth rate (AAGR) of 7.4%, the market will cross $13.8 billion in 2011.
- Ophthalmic pharmaceuticals dominated the market throughout the forecast period. In 2006 pharmaceuticals comprised 46.6% of the market and, growing at an AAGR of 6.9%, will be worth more than $6.2 billion and maintain more than 45% of the market in 2011.
- Contact lenses include both functional and cosmetic lenses. Contact lenses generate approximately $1.9 billion in revenues annually in the United States, accounting for a near 20% of the market.
|
Content
- Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope And Format
- Analyst Credentials
- BCC Online Services
- Disclaimer
- Summary
- Summary Table: U.S. Ophthalmic Market Forecast By Segment, Through 2011 ($ Million)
- Summary Figure: U.S. Ophthalmic Market Analysis By Segment, 2004-2011 ($ Million)
- Industry Overview
- Vision
- Structure Of The Eye
- Pathology
- Population Growth And Demographics
- Ophthalmic Conditions And Diseases
- Diabetic Retinopathy
- Age-Related Macular Degeneration
- Ocular Allergies
- Herpes Simplex Virus Keratitis
- Cytomegalovirus Retinitis
- Cataracts
- Glaucoma
- Uveitis
- Trachoma
- Retinal Detachment
- Dry Eye Syndrome
- Strabismus
- Ocular Muscle Spasms
- Issues Affecting The Market
- Litigation
- The Fda's Precautions Involving Lasik Eye Surgery
- Ophthalmic Pharmaceutical And Device Counterfeiting
- Ophthalmic Pharmaceutical/Device Recalls And Label Updates
- Government Interaction
- S. 2480: Contact Lens Consumer Protection Act
- S. 172
- Fairness To Contact Lens Consumers Act
- Advertising
- Pharmaceutical Side Effects And Ophthalmic Conditions
- Product Markets
- Prescription Ophthalmic Pharmaceuticals
- Product Descriptions
- Anti-Inflammatory Drugs
- Research And Development
- Anti-Infectives
- Antihistamines And Mast Cell Stabilizers
- Beta- Adrenergic Blockers
- Research And Development
- Prostaglandins
- Other Pharmaceutical Treatments
- Carbonic Anhydrase Inhibitors
- Dry Eye Treatments
- Miotics
- Mydriatics And Cycloplegics
- Ocular Anesthetics
- Ocular Muscle Spasm Treatments
- Pain Management Treatments
- Vasoconstrictors
- Other Treatments
- Research And Development
- Market Size And Growth
- Ophthalmic Diagnostics
- Product Descriptions
- Visual Acuity Test
- Dilated Eye Exam
- Manifest Refraction
- Pupil Reflex
- Tonometry Test
- Ophthalmoscopy
- Gonioscopy
- Slit Lamp Examinations
- Fluorescein Staining
- Eye Muscle Tests
- Corneal Thickness
- Pachymetry
- Echography
- Imaging Diagnostics
- Optic Nerve Imaging
- Optic Nerve Computer Imaging
- Aberrometer
- Innovative Imaging, Inc. And Echography
- Corneal Topography
- Flourescein Angiography
- Slit-Lamp Photography
- Specular Microscopy
- Glaucoma-Scope
- Fundus Cameras
- Market Size And Growth
- Competitive Structure And Market Share
- Vision Correction And Vision Preservation Devices
- Product Descriptions
- Soft (DISPOSABLE) Lenses
- Gas Permeable Lenses
- Cosmetic Lenses
- Shaping Lenses
- Market Size And Growth
- Competitive Structure And Market Share
- Surgical Equipment
- Product Descriptions
- Corneal Procedures
- Intracorneal Rings
- Cornea Transplants (Penetrating Keratoplasty)
- Deep Anterior Lamellar Corneal Transplant (DLEK)
- Dsek (Descemet's Stripping With Endothelial Keratoplasty)
- Lens Procedures
- Verisyse Lens Implant
- Lens Replacements
- Refractive Procedures
- Mechanical Microkeratome
- Blade-Free Microkeratome
- Lasek, Lasik, And Prk
- Retinal Procedures
- Vitreo-Retinal Surgery
- Surgical Procedures For Cataracts
- Phacoemulsification Cataract Surgery
- Endocapsular Tension Ring
- Surgical Procedures For Glaucoma
- Glaucoma Implant
- Neodymium: Yag Laser Cyclophotocoagulation (Yag Cp)
- Diode Laser Transscleral Cyclophotocoagulation (Diode Cyc)
- Selective Laser Trabeculoplasty (SLT)
- Argon Laser Trabeculoplasty (ALT)
- Laser Peripheral Iridotomy (LPI)
- Filtering Microsurgery
- Procedures For Age-Related Macular Degeneration (AMD)
- Focal Laser Treatment And Pdt
- Ophthalmic Lasers
- Blade-Free Femtosecond Microkeratome
- Excimer Laser
- Nd: Yag Lasers
- Other Laser Systems
- Intraocular Lenses And Other Lens Implants
- Shunts And Other Drainage Devices
- Research And Development
- Market Size And Growth
- Competitive Structure And Market Share
- Market Summary
- Total Ophthalmic Market
- Total Market Percentage Distribution By Market Segment
- Industry Participants By Product
- Technology
- Current Uses Of Technology
- Advanced Medical Optic's Wavescan/ Customvue Technology
- Crystalens By Eyeonics, Inc.
- Hybrid Lenses By Synergeyes, Inc.
- Silicone Hydrogel
- Vistakon's Senofilcon A Lens
- Vistakon's Highly Permeable Lens Technology
- Implantable Contact Lenses (Phakic Iol)
- Retisert Implant By Bausch & Lomb
- Orthokeratology
- Nike Maxsight
- Torsional Phacoemulsification
- Patent Evaluation By Drug
- Patent Evaluation By Technology
- New Technology Development
- Company Profiles
- Advanced Medical Optics, Inc.
- Alcon Laboratories, Inc.
- Allergan, Inc.
- Bausch & Lomb Inc.
- Carl Zeiss Ag
- Ciba Vision
- Coopervision, Inc.
- Merck & Co., Inc.
- New World Medical, Inc.
- Nidek Co., Ltd.
- Novartis International, Ag
- Pfizer, Inc.
- Staar Surgical Co.
- Vistakon
- Appendix: Ophthalmic Product Manufacturers
- List Of Ophthalmic Product Manufacturers
- List Of Figures
- Summary Table: U.S. Ophthalmic Market Forecast By Segment, Through 2011 ($ Million)
- Table 1 U.S. Incidence And Prevalence Of Selected Eye Conditions And Diseases
- Table 2 Glaucoma Types And Key Points
- Table 3 Known Causes Of Uveitis
- Table 4 Strabismus Types And Related Categories
- Table 5 Products With Ocular Recalls 2003-2006
- Table 6 Government Bills/Laws Related To Contact Lenses And Their Manufacturers
- Table 7 Selected Leading Ophthalmic Manufacturers/Providers In United States For 2005 ($)
- Table 8 Drug Combinations And Reported Side Effects, 2003-2006
- Table 9 Product Summary Of Ophthalmic Anti-Inflammatory Drugs By Manufacturer And Fda Approval Date
- Table 10 Product Summary Of Anti-Infectives By Manufacturer And Fda Approval Date
- Table 11 Products In Development For Anti-Infectives, By Manufacturer And Development Phase, 2006
- Table 12 Product Summary Of Selected Antihistamines And Mast Cell Stabliziers By Manufacturer And Fda Approval Date
- Table 13 Product Summary Of Beta Blockers By Manufacturer And Fda Approval Date
- Table 14 Beta Blockers In Development By Manufacturer And Development Phase
- Table 15 Product Summary Of Prostaglandins By Manufacturer And Fda Approval Date
- Table 16 Prostaglandins In Development By Manufacturer And Development Phase
- Table 17 Product Summary Of Other Pharmaceutical Treatments By Manufacturer, Product Type, And Fda Approval Date
- Table 18 Other Pharmaceutical Products In Development For Ophthalmic Conditions, By Manufacturer And Development Phase
- Table 19 U.S. Market Forecast For Ophthalmic Pharmaceuticals By Product Type, Through 2011 ($ Million)
- Table 20 Distribution Of Revenues For Ophthalmic Pharmaceuticals By Condition, 2006 (Percent/$ Million)
- Table 21 Competitive U.S. Market Share For Ophthalmic Pharmaceuticals By Manufacturer Revenues, 2006 ($ Million)
- Table 22 Select Conditions Found Through Slit-Lamp Photography
- Table 23 U.S. Market Forecast For Ophthalmic Diagnostics By Product Type, Through 2011 ($ Million)
- Table 24 Distribution Of U.S. Revenues For Ophthalmic Diagnostics By Condition, 2006 (%)
- Table 25 Competitive U.S. Market Share For Ophthalmic Diagnostics By Manufacturers Revenues, 2006 (%/$ Million)
- Table 26 U.S. Market Forecast For Contact Lenses By Type, Through 2011 ($ Million)
- Table 27 U.S. Competitive Market Share For Contact Lenses By Manufacturers Revenues, 2006 (Percent/$ Million)
- Table 28 Endoscapular Tension Rings Available By Manufacturer
- Table 29 Microkeratome/Femtosecond Systems By Manufacturer
- Table 30 Excimer Laser Systems By Manufacturer
- Table 31 Select Yag Laser Systems By Manufacturer
- Table 32 U.S. Market Forecast For Ophthalmic Surgical Equipment By Product Type, Through 2011 ($ Million)
- Table 33 Distribution Of U.S. Revenues For Ophthalmic Surgical Equipment By Condition, 2006 (%)
- Table 34 Competitive U.S. Market Share For Surgical Equipment By Manufacturers Revenues, 2006 (Percent/$ Million)
- Table 35 Total U.S. Ophthalmic Market Forecast, Through 2011 ($ Million)
- Table 36 Total U.S. Ophthalmic Market Forecast By Segment, Through 2011 ($ Million)
- Table 37 U.S. Market Summary Market Leaders By Product Type
- Table 38 U.S. Competitive Analysis For The U.S. Ophthalmic Market By Top Providers And Revenues, 2006 (Percent/$ Million)
- Table 39 Extended Wear Gas Permeable Soft Lenses By Manufacturer
- Table 40 U.S. Drug Patents For Ophthalmic Conditions
- Table 41 Number Of U.S. Patent Expirations By Year For Ophthalmic Drugs, 2006-2019
- Table 42 U.S. Ophthalmic Patent Evaluation By Major Technology
- List Of Figures
- Summary Figure: U.S. Ophthalmic Market Analysis By Segment, 2004-2011 ($ Million)
- Figure 1 U.S. Incidence And Prevalence Of Selected Eye Conditions And Diseases
- Figure 2 U.S. Market For Ophthalmic Pharmaceuticals By Product Type, 2004-2011 ($ Million)
- Figure 3 Distribution Of U.S. Revenues For Ophthalmic Pharmaceuticals By Condition, 2006 (%)
- Figure 4 Competitive U.S. Market Share For Ophthalmic Pharmaceuticals By Manufacturers Revenues, 2006 (%)
- Figure 5 U.S. Market For Ophthalmic Diagnostics By Product Type, 2004-2011 ($ Million)
- Figure 6 Distribution Of U.S. Revenues For Ophthalmic Diagnostics By Condition, 2006 (%)
- Figure 7 Competitive U.S. Market Share For Ophthalmic Diagnostics By Manufacturers Revenues, 2006 (%)
- Figure 8 U.S. Market For Contact Lenses By Type, 2004-2011 ($ Million)
- Figure 9 Competitive U.S. Market Share For Contact Lenses By Manufacturers Revenues, 2006 (%)
- Figure 10 U.S. Market For Surgical Equipment By Product Type, 2004-2011 ($ Million)
- Figure 11 Distribution Of U.S. Revenues For Ophthalmic Surgical Equipment By Condition, 2006 (%)
- Figure 12 Competitive U.S. Market Share For Surgical Equipment By Manufacturers Revenues, 2006 (%)
- Figure 13 Total U.S. Ophthalmic Market Forecast, 2004-2006, And 2011 ($ Million)
- Figure 14 U.S. Market Summary Total Ophthalmic Market, 2004-2011 ($ Million)
- Figure 15 U.S. Market Summary Total Ophthalmic Market, 2004-2011 (%)
|
|
|
